TSX:TLRY (Aphria)
About TLRY
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.
Aphria (TSX: TLRY) Latest News
Dividend Stocks
The New Anchor Tenants

Dividend Stocks
Investors: Don’t Miss Out on This $1.2 Trillion Opportunity
Dividend Stocks
Why Defensive Stocks Are an RSP Investor’s Best Friend
Dividend Stocks
How to Start Investing RSP Money
Investing
Is Jean Coutu Group PJC Inc. a Top Pick for 2017?
Investing
Canada’s Best Brands: They’re Perfect for Your Portfolio
Dividend Stocks
Jean Coutu Group PJC Inc. May Be Set for Another Takeoff!
Investing
Jean Coutu Group PJC Inc.: There Are Better Buys in the Pharmacy Space
Investing
2 Overlooked Dividend-Growth Stocks to Consider Today
Dividend Stocks
These 3 Canadian Companies Are Ripe to Be Acquired
